SHIRE PLC: Director/PDMR Shareholding
Director/PDMR Share Dealings
April 2, 2013 - Shire plc (LSE: SHP, NASDAQ: SHPG), (the "Company") announces that it was notified on March 28, 2013 that on the same day the Ordinary Shares ("Shares") and American Depository Shares ("ADSs") of the Company, as set out below, had been awarded under the Shire Executive Annual Incentive Plan ("EAIP") to Persons Discharging Managerial Responsibility ("PDMRs"). The Shares and ADSs were acquired on March 28, 2013 at prices of £19.94 per Share and $90.00 per ADS.
Type of Number of Security Shares/ADSs
Angus Russell (Chief Executive Officer) ADSs 3,123
Graham Hetherington (Chief Financial Shares 4,504 Officer)
Sylvie Gregoire ADSs 1,262
Jeffrey Jonas ADSs 932
Tatjana May Shares 2,702
The awards will normally be released to participants after a period of three years. One ADS is equal to three Shares.
In addition, the Company was notified on April 2, 2013 of the release of the following ADSs and Shares awarded in 2010 under the EAIP.
Type of Number of Number of Shares Security Shares/ADSs /ADSs sold to released satisfy tax liabilities
Angus Russell (Chief Executive ADSs 7,421 6,176 Officer)
Graham Hetherington (Chief Financial Shares 12,569 6,552 Officer)
Tatjana May Shares 7,515 3,918
On April 1 and April 2, 2013, sufficient ADSs and Shares were sold respectively, to satisfy tax liabilities as set out above. The ADSs and Shares were sold at prices of $90.9568 per ADS and £19.94 per Share.
The above transactions in Shares and ADSs took place on the London Stock Exchange and NASDAQ respectively.
This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a) of the Disclosure and Transparency Rules.
Tony Guthrie Deputy Company Secretary
For further information please contact:
Eric Rojas firstname.lastname@example.org +1 781 482 0999
Sarah Elton-Farr email@example.com +44 1256 894157
Notes to editors
Shire enables people with life-altering conditions to lead better lives.
Through our deep understanding of patients' needs, we develop and provide healthcare in the areas of:
* Behavioral Health and Gastro Intestinal conditions
* Rare Diseases * Regenerative Medicine as well as other symptomatic conditions treated by specialist physicians. We aspire to imagine and lead the future of healthcare, creating value for patients, physicians, policymakers, payors and our shareholders. Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX Press Release
-0- Apr/02/2013 15:05 GMT